Kazuki Okamoto Tomohiro Watanabe Yoriaki Komeda Ayana Okamoto Kosuke Minaga Ken Kamata Kentaro Yamao Mamoru Takenaka Satoru Hagiwara Toshiharu Sakurai Tomonori Tanaka Hiroki Sakamoto Kiyoshige Fujimoto Naoshi Nishida Masatoshi Kudo
10.3389/fimmu.2018.00918
Front Immunol
2018 May 7;9:918.
antibiotics cap polyposis inflammation intestinal microbiota next-generation sequencing
CC BY
https://pubmed.ncbi.nlm.nih.gov/29867933/
Anti-Bacterial Agents / therapeutic use Bacteria / drug effects Colonic Polyps / drug therapy Dysbiosis / complications Gastrointestinal Diseases / drug therapy Gastrointestinal Microbiome / drug effects
Anti-Bacterial Agents / therapeutic use Bacteria / drug effects Colonic Polyps / drug therapy Dysbiosis / complications Gastrointestinal Diseases / drug therapy Gastrointestinal Microbiome / drug effects Case Reports Research Support, Non-U.S. Gov't Ampicillin / therapeutic use Asymptomatic Diseases Bacteria / classification Colon / drug effects Colon / pathology Colonic Polyps / microbiology Dysbiosis / drug therapy Feces / microbiology Gastrointestinal Diseases / etiology High-Throughput Nucleotide Sequencing Humans Inflammation Male Metronidazole / therapeutic use Middle Aged Anti-Bacterial Agents Metronidazole Ampicillin
PMC5949673
29867933
Dysbiosis-Associated Polyposis of the Colon-Cap Polyposis
2018